Presentation NY Valves 2025 AVR in Asymptomatic Severe Aortic Stenosis: The EARLY TAVR Trial and Beyond Presenter: Brian R. Lindman June 26, 2025
Presentation NY Valves 2025 Is There Hope for Medical Management of Aortic Stenosis? New Potential Therapies for Prevention and Treatment Presenter: Brian R. Lindman June 25, 2025
Presentation TCT 2024 The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association) Presenter: Brian Lindman October 30, 2024
Presentation TCT 2024 Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program! Presenter: Brian Lindman October 30, 2024
Presentation NY Valves 2024 Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program Presenter: Brian R. Lindman June 07, 2024
Presentation TCT 2023 Pharmacotherapy to Slow AS Progression and Protect the Heart Presenter: Brian Lindman October 24, 2023
Presentation TCT 2023 Diagnosis to treatment of severe AS: should there be a Quality target for the US? Presenter: Brian Lindman October 24, 2023
Presentation THT 2023 Recurrent Heart Failure After AVR: Causes and Treatment Presenter: Brian Lindman March 22, 2023
Presentation TCT 2022 Access to Care in SHD Intervention: An Opportunity for Innovation? Presenter: Brian Lindman September 16, 2022
Presentation TVT 2019 Fix the Valve and Hope for the Best: Can We Do Better? Presenter: Brian Lindman June 12, 2019
Presentation The Structural Heart Disease Summit 2018 Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions Presenter: Brian R Lindman June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Perspectives on the Hierarchy of Valve Centers of Excellence in the US Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Brian R Lindman June 21, 2018
Presentation Early Regression of Severe LV Hypertrophy After TAVR Is Associated with Decreased Hospitalizations Presenter: Brian R. Lindman June 25, 2014
Presentation ESC 2013 Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort Presenter: Brian R. Lindman September 03, 2013